Archived Story

CDC to recommend fully vaccinated people wearing masks indoors in Covid hot spots

primary article image

PermaLink

Berkeley Lovelace Jr.

CNBC

Related: CNN, New York Times

Top News

BioNTech-Pfizer Covid vaccine shown safe and generated robust immune response in kids ages 5 to 11 in a clinical trial of 2200 children. A smaller dose of 10 μg (instead of the regular 30 μg for people 12 and older) was used in this study

primary article image

PermaLink

Berkeley Lovelace Jr.

CNBC

Related: NPR - National Public Radio

Two senior FDA leaders and vaccine experts to leave the Agency, citing frustration with CDC and White House for interference with FDA’s vaccine decision making process

primary article image

PermaLink

Zachary Brennan

Endpoints News

Related: CNBC

CNBC: developing mRNA vaccine in record time - story of Moderna and Pfizer-BioNTech

primary article image

PermaLink

CNBC

YouTube


Lilly & Boehringer: Jardiance lowered 21% risk in distolic heart failure in a landmark study of 6000 patients. FDA just approved this drug last week for systolic heart failure

primary article image

PermaLink

Madeleine Armstrong

Vantage

Related: MarketWatch, FiercePharma, New England Journal of Medicine (NEJM)

Full approval granted to BioNTech-Pfizer’s Covid vaccine by FDA for patients age 16 and up

primary article image

PermaLink

Berkeley Lovelace Jr.

CNBC

Related: New York Times

BioNTech Q2 vaccine sales soared to $6.24 billion, expect 2021 total sales to be $18.7 billion. The Company and partner Pfizer have supplied more than 1 billion COVID-19 vaccine doses worldwide so far

primary article image

PermaLink

Ludwig Burger

yahoo

Related: BioNTech, Investor's Business Daily

Moderna's COVID vaccine shown durable efficacy of 93% at 6-month (vs. BioNTech-Pfizer 83.7%). The Company also developing 3 booster candidates, all 3 showed robust antibody responses against Gamma, Beta, and Delta variants in a phase 2 study

primary article image

PermaLink

CNBC

YouTube

Related: Moderna, Inc., Investor's Business Daily, CNBC, New York Times

Biotech company Vaxart to start a phase 2 study of S-Only oral COVID vaccine. The Company completed a phase 1 study for its S+N vaccine. New data shows S-Only version yields stronger immune response than S+N

primary article image

PermaLink

Staff Writer

yahoo


‘Fast and furious’: Israel to give 1.5M seniors booster shot of Covid vaccine in 8 days. President Herzog and his wife have both received booster shots

primary article image

PermaLink

MAAYAN JAFFE-HOFFMAN

The Jerusalem Post | JPost.com

Related: timesofisrael, YouTube

CDC: delta variant as contagious as chickenpox. Covid vaccine can cut risk of severe disease and death “10-fold or greater” and reduce the risk of infection “3-fold”

primary article image

PermaLink

Paul Leblanc

CNN

Related: CNBC, New York Times

Batteled by setbacks, controversies, and money-lossing sales, AstraZeneca re-evaluates its COVID vaccine business. The Company to file for FDA approval by the end of 2021

primary article image

PermaLink

Angus Liu

FiercePharma

Related: The Guardian, Reuters

Study shown BioNTech-Pfizer's Covid vaccine effectiveness drops to 84% after six months. Company says third dose 'strongly' boosts protection against Delta variant, and pushes to immunize school age kids

primary article image

PermaLink

Anjalee Khemlani

yahoo

Related: CNN, medRxiv, CNBC

Pfizer posts $7.8 billion sales in Covid vaccine for Q2, expects 2021 full year sales for the vaccine to be $33.5 billion

primary article image

PermaLink

Berkeley Lovelace Jr.

CNBC

Related: MarketWatch

CDC to recommend fully vaccinated people wearing masks indoors in Covid hot spots

primary article image

PermaLink

Berkeley Lovelace Jr.

CNBC

Related: CNN, New York Times

Israel to let 5 to 11-year-old kids with "maximum risk of serious Covid disease or even deaths" to get reduced dose of COVID-19 vaccine. Also, the approval a COVID booster shot is imminent

primary article image

PermaLink

MAAYAN JAFFE-HOFFMAN

The Jerusalem Post | JPost.com

Related: timesofisrael

Johnson & Johnson revenue and profit increase, its Covid vaccine to generate $2.5 billion global sales in 2021

primary article image

PermaLink

Berkeley Lovelace Jr.

CNBC


Three days to go, Tokyo 2020 CEO won't rule out last-minute cancellation of Olympics, as more athletes tested positive for COVID-19, major sponsors dropped plans to attend Friday's opening ceremony, and COVID-19 cases are rising in Tokyo

primary article image

PermaLink

Reuters Staff

ESPN.com

Related: yahoo, CNN

US stocks fell sharply on fear of resurgence in Covid cases. Dow dropped 900 points and Nasdaq lost 200 points. Airlines, Boeing, cruise lines stocks tumble

primary article image

PermaLink

Tanaya Macheel

CNBC

Related: yahoo, New York Times

BioNTech/Pfizer Covid vaccine: priority review granted by FDA; generates 10X antibody than Sinovac vaccine (LANCET study); may be used as booster shot in China for those fully vaccinated with vaccines of Chinese companies

primary article image

PermaLink

Jamie Gumbrecht

CNN

Related: thediplomat, yahoo, Nikkei Asian Review, Caixin, The Lancet, South China Morning Post

Moderna aims higher after triumph in Covid vaccine - Bloomberg

primary article image

PermaLink

Robert Langreth

Bloomberg

Latest News

Pfizer And BioNTech Say Vaccine Trial For Kids Shows Its Safe And Effective

19 Sep 2021 • 8:00 PM EDT, Jaclyn Diaz, NPR - National Public Radio


Pfizer says its Covid vaccine is safe and generates robust immune response in kids ages 5 to 11

19 Sep 2021 • 8:00 PM EDT, Berkeley Lovelace Jr., CNBC


BREAKING: In a major blow to vaccine efforts, senior FDA leaders stepping down

31 Aug 2021 • 3:13 PM EDT, Zachary Brennan, Endpoints News


Two senior FDA vaccine regulators are stepping down

30 Aug 2021 • 8:00 PM EDT, Berkeley Lovelace Jr., CNBC


ESC 2021 – Jardiance blows Entresto out of the water

27 Aug 2021 • 8:00 PM EDT, Madeleine Armstrong, Vantage


Lilly, Boehringer Ingelheim: Jardiance Shows 21% Relative Risk Reduction in Diastolic Heart Failure

27 Aug 2021 • 4:47 PM EDT, Staff Writer, MarketWatch


ESC 2021: Eli Lilly, Boehringer's Jardiance racks up data for 2nd nod in crowded heart failure field

27 Aug 2021 • 4:38 PM EDT, Fraiser Kansteiner, FiercePharma


Empagliflozin and Major Renal Outcomes in Heart Failure

27 Aug 2021 • 4:23 PM EDT, S.D. Anker Et Al., New England Journal of Medicine (NEJM)


How Moderna And Pfizer-BioNTech Developed Vaccines In Record Time

27 Aug 2021 • 1:55 PM EDT, CNBC, YouTube


Covid-19 Updates: F.D.A. Grants Full Approval to Pfizer-BioNTech Covid Vaccine

22 Aug 2021 • 8:00 PM EDT, Sharon Lafraniere, New York Times


FDA grants full approval to Pfizer-BioNTech’s Covid shot, clearing path to more vaccine mandates

22 Aug 2021 • 8:00 PM EDT, Berkeley Lovelace Jr., CNBC


BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update

09 Aug 2021 • 10:00 AM EDT, Staff Writer, BioNTech


BioNTech says has supplied more than 1 billion COVID-19 vaccine doses so far

09 Aug 2021 • 9:42 AM EDT, Ludwig Burger, yahoo


BioNTech Stock Pops On Massive Earnings Beat; Company Looks Beyond Covid

09 Aug 2021 • 9:03 AM EDT, Allison Gatlin, Investor's Business Daily


Moderna CEO on its latest vaccine efficacy data

05 Aug 2021 • 10:23 AM EDT, CNBC, YouTube


Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates

05 Aug 2021 • 10:02 AM EDT, Staff Writer, Moderna, Inc.


Moderna Stock: Moderna Earnings Crush Views; Covid Vaccine Maker Guides Higher, Sets Buyback

05 Aug 2021 • 7:17 AM EDT, Investor'S Business Daily, Investor's Business Daily


Moderna says its Covid vaccine booster produced ‘robust’ immune response against delta

04 Aug 2021 • 8:00 PM EDT, Berkeley Lovelace Jr., CNBC


Moderna says its vaccine’s protection holds through six months, but the Delta variant may require boosters.

04 Aug 2021 • 8:00 PM EDT, Carl Zimmer, New York Times


FDA Clears Vaxart's IND Application for S-Only Oral Tablet COVID-19 Vaccine Candidate

02 Aug 2021 • 9:24 AM EDT, Staff Writer, yahoo